 | | PRD_000814 | | Name: | N-{[(3R,4R,7S,10R,11R)-3-ethyl-11,15-dihydroxy-3-methyl-10-(methylamino)-6,9-dioxo-7-(propan-2-yl)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),12,14-trien-4-yl]carbonyl}glycine | | Formula: | C23 H34 N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000823 | | Name: | N-propanoyl-D-alanyl-(4R)-4-[(7-bromoisoquinolin-1-yl)oxy]-N-{(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-L-prolinamide | | Formula: | C29 H34 Br N5 O7 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000842 | | Name: | PTA-SFTI INHIBITOR | | Formula: | C66 H106 N20 O18 S2 | | Description: | Bowman-Birk Inhibitor | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000846 | | Name: | TRYPSIN INHIBITOR 1 | | Formula: | C66 H106 N20 O18 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000857 | | Name: | SAH-p53-8 stapled-peptide | | Formula: | C96 H151 N26 O25 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002417 | | Name: | Ac-VRHA-conh-[4-(4-butyl)-phenoxy-1-phenyl-2-butyl] | | Formula: | C43 H66 N10 O7 | | Definition date: | 2023-10-25 | | Last modified: | 2023-10-25 |
|
 | | PRD_002443 | | Name: | SiaLac-amidine-Lys | | Formula: | C33 H57 N5 O20 S | | Definition date: | 2023-09-27 | | Last modified: | 2023-09-27 |
|
 | | PRD_002387 | | Name: | tert-butyl N-[5-phenyl-3-(2-phenylethylcarbamoyl)thiophen-2-yl]carbamate | | Formula: | C24 H26 N2 O3 S | | Definition date: | 2023-09-27 | | Last modified: | 2023-09-27 |
|
 | | PRD_000102 | | Name: | CYCLIC HEXAPEPTIDE RR(NAL)(NAL)RF | | Formula: | C53 H70 N15 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000103 | | Name: | CYCLIC HEXAPEPTIDE KKWWKF | | Formula: | C49 H68 N11 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000104 | | Name: | CYCLIC HEXAPEPTIDE RRYYRF | | Formula: | C45 H66 N15 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000105 | | Name: | CYCLIC HEXAPEPTIDE CYC-(RRWWRF) | | Formula: | C49 H68 N17 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000106 | | Name: | BOC-(D-NLE-L-NLE)4-D-NLE(METHYL)-L-NLE-D-NLE-L-NLE METHYL ESTER | | Formula: | C79 H146 N12 O15 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000107 | | Name: | H-(L-TYR-D-TYR)4-LYS-OH | | Formula: | C78 H87 N10 O18 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000108 | | Name: | HCO-(D-NLE-L-NLE)3-D-MENLE-L-NLE-D-NLE-L-NLE-OME | | Formula: | C63 H116 N10 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000109 | | Name: | BOC-L-NLE-(D-NLE-L-NLE)5-D-NLE(METHYL)-L-NLE-D-NLE-L-NLE METHYL ESTER | | Formula: | C96 H177 N15 O18 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000110 | | Name: | DLY-HGL-AGD-LHC-AGD-LHC-CUD-LYS | | Formula: | C60 H81 N34 O15 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000117 | | Name: | ARYLOMYCIN A2 | | Formula: | C42 H60 N6 O11 | | Description: | ARYLOMYCIN A2 IS A BIARYL-BRIDGED LIPOPEPTIDE. THE SCAFFOLD IS MADE OF TWO PARTS: (1) N-TERM EXOCYCLIC TRIPEPTIDE (2)
A TRICYCLIC PEPTIDE, WITH [3,3] BIARYL BOND BETWEEN RESIDUE 4 AND 6 AN ISO-C12 FATTY ACID IS LINKED TO RESIDUE 1. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000142 | | Name: | Cyclosporin A | | Formula: | C62 H111 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000143 | | Name: | Cyclosporin D | | Formula: | C64 H115 N11 O12 S | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000144 | | Name: | Cyclosporin C | | Formula: | C62 H111 N11 O13 | | Description: | CYCLOSPORIN C IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN C IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS
FROM CYCLOSPORIN A IN RESIDUE 6 (ABA6THR). | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000150 | | Name: | GRAMICIDIN A | | Formula: | C99 H140 N20 O17 | | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000151 | | Name: | GRAMICIDIN B | | Formula: | C97 H139 N19 O17 | | Description: | GRAMICIDIN B IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000152 | | Name: | GRAMICIDIN D | | Formula: | C99 H140 N20 O17 | | Description: | GRAMICIDIN D IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 1).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000153 | | Name: | GRAMICIDIN C | | Formula: | C99 H140 N20 O17 | | Description: | GRAMICIDIN C IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
